Alumis (ALMS) EPS (Basic) (2023 - 2026)
Alumis (ALMS) posted quarterly EPS (Basic) of -$1.09 for Q4 2025, up 5.37% year-over-year from -$1.04 in Q4 2024, and down 2.65% quarter-over-quarter from -$1.06 in Q3 2025.
Alumis (ALMS) EPS (Basic) (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported EPS (Basic) for 3 consecutive years, with -$1.09 the latest figure, recorded in Q4 2025.
- In Q4 2025, EPS (Basic) rose 5.37% year-over-year to -$1.09; the TTM figure through Dec 2025 stood at -$2.95 (up 63.6% YoY), while the FY2025 annual figure was -$2.86, up 64.85% from the prior year.
- EPS (Basic) eased to -$1.09 in Q4 2025 per ALMS's latest filing, from -$1.06 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.77 in Q2 2025 and bottomed at -$20.93 in Q2 2024.
- Historically, EPS (Basic) has averaged -$5.55 across 3 years, with a median of -$1.73 in 2024.
- Annual changes were most pronounced in 2024 — EPS (Basic) tumbled 50.33% — and 2025, when it surged 103.7%.
- Alumis' EPS (Basic) stood at -$1.73 in 2023, then jumped by 33.4% to -$1.15 in 2024, then grew by 5.37% to -$1.09 in 2025.
- Business Quant data shows ALMS's EPS (Basic) at -$1.09 in Q4 2025, -$1.06 in Q3 2025, and $0.77 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Alumis | 3.25 Bn | 2.75 Bn | - | -1.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.11 |
| Dec 31, 2025 | -1.09 |
| Sep 30, 2025 | -1.06 |
| Jun 30, 2025 | 0.77 |
| Mar 31, 2025 | -1.96 |
| Dec 31, 2024 | -1.15 |
| Sep 30, 2024 | -1.73 |
| Jun 30, 2024 | -20.93 |
| Mar 31, 2024 | -1.48 |
| Dec 31, 2023 | -1.73 |
| Sep 30, 2023 | -16.82 |
| Jun 30, 2023 | -13.92 |